 Endocrine-metabolic function remission-phase IDDM administration cyclosporine endocrine-metabolic status patients non-insulin-receiving NIR remission insulin-dependent diabetes IDDM mo diagnosis administration cyclosporine comparison nondiabetic subjects IDDM patients NIR remission target glycemic control plasma glucose mean capillary blood glucose levels mM meals administration insulin wk so-called isoglycemic tests glucose glycemic curve subsequent study programmed intravenous infusion glucose conditions subjects diabetes obvious glucose intolerance acute beta-cell responses intravenous glucose absent significant subnormal responses present oral glucose responses plasma immunoreactive gastric inhibitory polypeptide oral glucose normal bolus intravenous injections glucose patients diabetes glucose intolerance acute responses immunoreactive insulin IRI C-peptide present intravenous infusion arginine min patients diabetes substantial subnormal increases plasma IRI C-peptide Intravenous infusion arginine increments plasma immunoreactive glucagon IRGI groups response patients diabetes ingestion standard mixed meal Sustacal cal modest increase plasma glucose levels diabetic subjects